135 related articles for article (PubMed ID: 16759617)
1. [Contribution of PET in the follow-up of cerebral metastases in non-small cell lung cancer. A clinical case valuation].
Ferrer Rebolleda J; Ortega de los Mártires F; Santos Cores J; Menéndez López A; Arribas Alpuente L; Almenar Medina S
Rev Esp Med Nucl; 2006; 25(2):107-12. PubMed ID: 16759617
[TBL] [Abstract][Full Text] [Related]
2. FDG-PET in the evaluation of response to nivolumab in recurrent non-small-cell lung cancer.
Higuchi M; Owada Y; Inoue T; Watanabe Y; Yamaura T; Fukuhara M; Hasegawa T; Suzuki H
World J Surg Oncol; 2016 Sep; 14(1):238. PubMed ID: 27595749
[TBL] [Abstract][Full Text] [Related]
3. Intramedullary metastases due to non microcytic lung carcinoma.
Maciá Escalante S; Martínez Ortiz MJ; Guillén Ponce C; Rodríguez Lescure A; Gallego Plazas J; Carrato Mena A
Clin Transl Oncol; 2006 Jun; 8(6):459-60. PubMed ID: 16790402
[No Abstract] [Full Text] [Related]
4. Oligo-recurrence from a lung adenocarcinoma. Usefulness of resection.
García Rodríguez ME; Armas Pérez BA; Armas Moredo K
Arch Bronconeumol; 2014 Jan; 50(1):46-7. PubMed ID: 24315185
[No Abstract] [Full Text] [Related]
5. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
6. [Stereotactic body radiation radiotherapy for oligometastatic non-small cell lung cancer (NSCLC): A case report].
Leduc C; Antoni D; Quoix É; Noël G
Cancer Radiother; 2015 May; 19(3):192-7. PubMed ID: 25841992
[TBL] [Abstract][Full Text] [Related]
7. Surgical treatment of primary lung cancer with synchronous brain metastases.
Billing PS; Miller DL; Allen MS; Deschamps C; Trastek VF; Pairolero PC
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):548-53. PubMed ID: 11547308
[TBL] [Abstract][Full Text] [Related]
8. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
9. [The boundaries of curation].
Debus J; Eberhardt W; Hoffmann H; Passlick B; Rübe C; Thomas M
Onkologie; 2010; 33 Suppl 5():12-20. PubMed ID: 20523102
[TBL] [Abstract][Full Text] [Related]
10. Value of combined interpretation of computed tomography response and positron emission tomography response for prediction of prognosis after neoadjuvant chemotherapy in non-small cell lung cancer.
Lee HY; Lee HJ; Kim YT; Kang CH; Jang BG; Chung DH; Goo JM; Park CM; Lee CH; Kang KW
J Thorac Oncol; 2010 Apr; 5(4):497-503. PubMed ID: 20195167
[TBL] [Abstract][Full Text] [Related]
11. The role of prophylactic cranial radiation in the treatment of non-small-cell lung cancer.
Laskin JJ; Sandler AB
Clin Adv Hematol Oncol; 2003 Dec; 1(12):731-34. PubMed ID: 16258477
[TBL] [Abstract][Full Text] [Related]
12. Lung cancer and Rosai-Dorfman's disease. A clinicopathological study.
Lutterbach J; Henne K; Pagenstecher A; Böhm J
Strahlenther Onkol; 2003 Jul; 179(7):486-92. PubMed ID: 12835886
[TBL] [Abstract][Full Text] [Related]
13. Lung cancer and its operable brain metastasis: survival rate and staging problems.
Furák J; Troján I; Szöke T; Agócs L; Csekeö A; Kas J; Svastics E; Eller J; Tiszlavicz L
Ann Thorac Surg; 2005 Jan; 79(1):241-7; discussion 241-7. PubMed ID: 15620950
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic radiosurgery for the management of brain metastases.
Suh JH
N Engl J Med; 2010 Mar; 362(12):1119-27. PubMed ID: 20335588
[No Abstract] [Full Text] [Related]
15. [PET scan and NMR spectroscopy for the differential diagnosis between brain radiation necrosis and tumour recurrence after stereotactic irradiation of brain metastases: Place in the decision tree].
Menoux I; Noël G; Namer I; Antoni D
Cancer Radiother; 2017 Aug; 21(5):389-397. PubMed ID: 28599998
[TBL] [Abstract][Full Text] [Related]
16. Results of recent therapy for non-small-cell lung cancer with brain metastasis as the initial relapse.
Ohta Y; Oda M; Tsunezuka Y; Uchiyama N; Nishijima H; Takanaka T; Ohnishi H; Kohda Y; Yamashita J; Watanabe G
Am J Clin Oncol; 2002 Oct; 25(5):476-9. PubMed ID: 12393988
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of pulmonary adenocarcinoma due to hip bone metastasis.
Puertas García-Sandoval JP; Valcárcel Díaz A; Calatayud Mora JA
Arch Bronconeumol; 2013 Jan; 49(1):37-8. PubMed ID: 22980134
[No Abstract] [Full Text] [Related]
18. FDG PET/CT imaging in prostate adenocarcinoma presenting as isolated brain metastases of unknown origin.
Erhamamcı S; Reyhan M; Alkan O
Rev Esp Med Nucl Imagen Mol; 2015; 34(2):146-7. PubMed ID: 25052407
[No Abstract] [Full Text] [Related]
19. Differentiation of local tumor recurrence from radiation-induced changes after stereotactic radiosurgery for treatment of brain metastasis: case report and review of the literature.
Kickingereder P; Dorn F; Blau T; Schmidt M; Kocher M; Galldiks N; Ruge MI
Radiat Oncol; 2013 Mar; 8():52. PubMed ID: 23497597
[TBL] [Abstract][Full Text] [Related]
20. Development of brain metastasis 5 years before the appearance of the primary lung cancer: "messenger metachronous metastasis".
Furák J; Troján I; Tiszlavicz L; Micsik T; Puskás LG
Ann Thorac Surg; 2003 Mar; 75(3):1016-7. PubMed ID: 12645740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
